Oncology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

Sep 2021| TBR951E| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Cancer; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others
2) By Drug Class Type: Chemotherapy; Targeted Therapy; Immunotherapy (Biologic Therapy); Hormonal Therapy
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
4) By Route of Administration: Oral; Parenteral; Others
5) By Drug Classification: Branded Drugs; Generic Drugs
Covering: Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Merck & Co., Inc.; Novartis AG; Johnson & Johnson; Pfizer Inc.; AstraZeneca PLC; AbbVie Inc.; Amgen; Eli Lilly

Oncology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global Oncology Drugs market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Description:
Where is the largest and fastest growing market for the Oncology Drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oncology Drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Oncology Drugs market, and compares it with other markets.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, segmentation by drug class type, segmentation by distribution channel, segmentation by route of administration and segmentation by drug classification.
  • Market Characteristics – The market characteristics section of the report defines and explains the oncology drugs market. This chapter also defines and describes goods and related services covered in the report.
  • Supply Chain – The supply chain section of the report defines and explains the key players in the oncology drugs industry supply chain.
  • Product Analysis – The product analysis section of the report describes the leading products in the oncology drugs market along with key features and differentiators for those products.
  • Customer Information – This chapter covers recent customers’ trends/preferences in the global oncology drugs market.
  • Trends And Strategies – This chapter describes the major trends shaping the global oncology drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Oncology Drug Therapies – This section describes the major therapies in the market to effectively treat different cancer types.
  • Gene Therapy – This chapter describes the different futuristic gene therapies to treat or prevent the spread of cancer.
  • Unmet Needs In Oncology Drugs – This chapter describes the several unmet needs in the oncology drugs market which are expected to reach the market in the future.
  • Drugs In Pipeline – This section covers list of latest drugs in pipeline and their description.
  • Top Oncology Drugs – This section provides information of the top 10 drugs that are used to treat cancer by the revenue generated and company that has developed the drug.
  • Impact of COVID-19 – This section describes the impact of COVID-19 on the oncology drugs market.
  • Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
  • Global Macro Comparison – The global oncology drugs market comparison with macro-economic factors gives the oncology drugs market size, percentage of GDP, and average oncology drugs market expenditure.
  • Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global oncology drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background – This section describes the pharmaceutical drugs market of which the oncology drugs market is a segment. This chapter includes the global pharmaceutical drugs market 2015-20 and 2020-25 values, and regional and country analyses for the pharmaceutical drugs market.
  • Opportunities And Strategies – This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for oncology drugs manufacturers in terms of product offerings, geographic expansion, price offerings, and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

 

 

Scope

Markets Covered:

  • By Type: Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Cancer; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others
  • By Drug Class Type: Chemotherapy; Targeted Therapy; Immunotherapy (Biologic Therapy); Hormonal Therapy
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
  • By Route of Administration: Oral; Parenteral; Others
  • By Drug Classification: Branded Drugs; Generic Drugs

Companies Mentioned: Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Merck & Co., Inc.; Novartis AG; Johnson & Johnson; Pfizer Inc.; AstraZeneca PLC; AbbVie Inc.; Amgen; Eli Lilly

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, Oncology Drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 2 : Global Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 3 : Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 4 : Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 5 : Global Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
  • Table 6 : Global Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
  • Table 7 : Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 8 : Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 9 : Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10 : Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11 : Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 12 : Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 13 : Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 14 : Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 15 : Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 16 : Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 17 : Global Oncology Drugs Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2025
  • Table 18 : Global Oncology Drugs Market, Per Capita Average Oncology Drugs Market Industry Expenditure, 2015 – 2025, ($)
  • Table 19 : Asia Pacific, GDP Per Capita, 2015-2020, $
  • Table 20 : Asia-Pacific, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 21 : Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 22 : Asia-Pacific, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 23 : Asia-Pacific Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 24 : Asia-Pacific Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 25 : Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 26 : Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 27 : Asia-Pacific Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Table 28 : Asia-Pacific Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 29 : Asia-Pacific Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 30 : Asia-Pacific Per Capita Oncology Drugs Expenditure, By Country, 2020, $
  • Table 31 : China, GDP Per Capita, 2015-2020, $
  • Table 32 : China, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 33 : China, Population By Age Group, 2015-2023, Thousands
  • Table 34 : China, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 35 : China Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 36 : China Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 37 : China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 38 : China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 39 : Australia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 40 : Australia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 41 : Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 42 : Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 43 : Hong Kong Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 44 : Hong Kong Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 45 : India GDP Per Capita, 2015-2020, $
  • Table 46 : India, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 47 : India, Population By Age Group, 2015-2023, Thousands
  • Table 48 : India, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 49 : India Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 50 : India Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 51 : India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 52 : India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 53 : Indonesia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 54 : Indonesia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 55 : Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 56 : Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 57 : Japan GDP Per Capita, 2015-2020, $
  • Table 58 : Japan, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 59 : Japan, Population By Age Group, 2015-2023, Thousands
  • Table 60 : Japan, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 61 : Japan Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 62 : Japan Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 63 : Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 64 : Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 65 : Malaysia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 66 : Malaysia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 67 : New Zealand Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 68 : New Zealand Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 69 : Philippines Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 70 : Philippines Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 71 : Singapore Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 72 : Singapore Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 73 : South Korea Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 74 : South Korea Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 75 : South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 76 : South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 77 : Thailand Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 78 : Thailand Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 79 : Vietnam Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 80 : Vietnam Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 81 : Western Europe, GDP Per Capita, 2015-2020, $
  • Table 82 : Western Europe, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 83 : Western Europe, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 84 : Western Europe, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 85 : Western Europe Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 86 : Western Europe Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 87 : Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 88 : Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 89 : Western Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Table 90 : Western Europe Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 91 : Western Europe Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 92 : Western Europe Per Capita Oncology Drugs Expenditure, By Country, 2020, $
  • Table 93 : Austria Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 94 : Austria Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 95 : Belgium Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 96 : Belgium Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 97 : Denmark Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 98 : Denmark Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 99 : Finland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 100 : Finland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 101 : France Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 102 : France Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 103 : France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 104 : France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 105 : Germany Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 106 : Germany Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 107 : Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 108 : Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 109 : Ireland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 110 : Ireland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 111 : Italy Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 112 : Italy Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 113 : Netherlands Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 114 : Netherlands Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 115 : Norway Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 116 : Norway Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 117 : Portugal Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 118 : Portugal Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 119 : Spain Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 120 : Spain Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 121 : Sweden Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 122 : Sweden Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 123 : Switzerland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 124 : Switzerland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 125 : UK GDP Per Capita, 2015-2020, $
  • Table 126 : UK, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 127 : UK, Population By Age Group, 2015-2023, Thousands
  • Table 128 : UK, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 129 : UK Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 130 : UK Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 131 : UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 132 : UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 133 : Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 134 : Eastern Europe Oncology Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 135 : Eastern Europe Oncology Drugs Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 136 : Eastern Europe Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 137 : Eastern Europe Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 138 : Eastern Europe Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 139 : Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 140 : Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 141 : Eastern Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Table 142 : Eastern Europe Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 143 : Eastern Europe Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 144 : Eastern Europe Per Capita Oncology Drugs Expenditure, By Country, 2020, $
  • Table 145 : Czech Republic Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 146 : Czech Republic Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 147 : Poland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 148 : Poland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 149 : Romania Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 150 : Romania Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 151 : Russia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 152 : Russia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 153 : Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 154 : Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 155 : North America GDP Per Capita, 2015-2020, $
  • Table 156 : North America, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 157 : North America, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 158 : North America, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 159 : North America Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 160 : North America Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 161 : North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 162 : North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 163 : North America Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Table 164 : North America Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 165 : North America Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 166 : North America Per Capita Oncology Drugs Expenditure, By Country, 2020, $
  • Table 167 : Canada Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 168 : Canada Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 169 : Mexico Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 170 : Mexico Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 171 : USA GDP Per Capita, 2015-2020, $
  • Table 172 : USA, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 173 : USA, Population By Age Group, 2015-2023, Thousands
  • Table 174 : USA, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 175 : USA Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 176 : USA Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 177 : USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 178 : USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 179 : South America GDP Per Capita, 2015-2020, $
  • Table 180 : South America, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 181 : South America, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 182 : South America, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 183 : South America Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 184 : South America Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 185 : South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 186 : South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 187 : South America Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Table 188 : South America Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 189 : South America Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 190 : South America Per Capita Oncology Drugs Expenditure, By Country, 2020, $
  • Table 191 : Argentina Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 192 : Argentina Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 193 : Brazil Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 194 : Brazil Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 195 : Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 196 : Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 197 : Chile Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 198 : Chile Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 199 : Colombia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 200 : Colombia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 201 : Peru Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 202 : Peru Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 203 : Venezuela Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 204 : Venezuela Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 205 : Middle East GDP Per Capita, 2015-2020, $
  • Table 206 : Middle East, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 207 : Middle East, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 208 : Middle East Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 209 : Middle East Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 210 : Middle East Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 211 : Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 212 : Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 213 : Middle East Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Table 214 : Middle East Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 215 : Middle East Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 216 : Middle East Per Capita Oncology Drugs Expenditure, By Country, 2020, $
  • Table 217 : Saudi Arabia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 218 : Saudi Arabia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 219 : Israel Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 220 : Israel Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 221 : Turkey Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 222 : Turkey Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 223 : UAE Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 224 : UAE Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 225 : Africa GDP Per Capita, 2015-2020, $
  • Table 226 : Africa, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 227 : Africa, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 228 : Africa, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 229 : Africa Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 230 : Africa Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 231 : Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 232 : Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 233 : Africa Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Table 234 : Africa Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 235 : Africa Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 236 : Egypt Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 237 : Egypt Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 238 : Nigeria Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 239 : Nigeria Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 240 : South Africa Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 241 : South Africa Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 242 : Global Oncology Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 243 : Bristol-Myers Squibb Company – Financial Performance, 2016 – 2020, $ Billion
  • Table 244 : F. Hoffmann-La Roche AG – Financial Performance, 2016 – 2020, $ Billion
  • Table 245 : Merck & Co., Inc. – Financial Performance, 2016 - 2020, $ Billion
  • Table 246 : Novartis AG – Financial Performance, 2016 – 2020, $ Billion
  • Table 247 : Johnson & Johnson (J&J) – Financial Performance, 2016 – 2020, $ Billion
  • Table 248 : Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
  • Table 249 : Global Pharmaceutical Drugs Market, 2020, Split By Region
  • Table 250 : Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
  • Table 251 : Global Oncology Drugs Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 252 : Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
  • Table 253 : Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
  • Table 254 : Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Route Of Administration, 2020 – 2025
  • Table 255 : Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Drug Classification, 2020 – 2025
  • Table 256 : Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Mode Of Purchase, 2020 – 2025
  • Figure 1 : Global Oncology Drugs Market Segmentation By Type
  • Figure 2 : Global Oncology Drugs Market Segmentation By Drug Class Type
  • Figure 3 : Global Oncology Drugs Market Segmentation By Distribution Channel
  • Figure 4 : Global Oncology Drugs Market Segmentation By Route Of Administration
  • Figure 5 : Global Oncology Drugs Market Segmentation By Drug Classification
  • Figure 6 : Market Supply Chain For Oncology Drugs
  • Figure 7 : Global Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 8 : Global Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 9 : Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 10 : Global Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
  • Figure 11 : Global Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
  • Figure 12 : Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 13 : Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 14 : Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15 : Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 16 : Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 17 : Asia-Pacific Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 18 : Asia-Pacific Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 19 : Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 20 : Asia-Pacific Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 21 : Asia-Pacific Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 22 : Asia-Pacific Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 23 : China Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 24 : China Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 25 : China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 26 : Australia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 27 : Australia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 28 : Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 29 : Hong Kong Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 30 : Hong Kong Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 31 : India Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 32 : India Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 33 : India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 34 : Indonesia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 35 : Indonesia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 36 : Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 37 : Japan Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 38 : Japan Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 39 : Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 40 : Malaysia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 41 : Malaysia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 42 : New Zealand Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 43 : New Zealand Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 44 : Philippines Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 45 : Philippines Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 46 : Singapore Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 47 : Singapore Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 48 : South Korea Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 49 : South Korea Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 50 : South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 51 : Thailand Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 52 : Thailand Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 53 : Vietnam Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 54 : Vietnam Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 55 : Western Europe Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 56 : Western Europe Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 57 : Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 58 : Western Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 59 : Western Europe Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 60 : Western Europe Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 61 : Austria Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 62 : Austria Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 63 : Belgium Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 64 : Belgium Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 65 : Denmark Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 66 : Denmark Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 67 : Finland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 68 : Finland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 69 : France Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 70 : France Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 71 : France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 72 : Germany Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 73 : Germany Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 74 : Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 75 : Ireland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 76 : Ireland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 77 : Italy Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 78 : Italy Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 79 : Netherlands Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 80 : Netherlands Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 81 : Norway Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 82 : Norway Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 83 : Portugal Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 84 : Portugal Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 85 : Spain Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 86 : Spain Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 87 : Sweden Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 88 : Sweden Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 89 : Switzerland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 90 : Switzerland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 91 : UK Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 92 : UK Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 93 : UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 94 : Eastern Europe Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 95 : Eastern Europe Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 96 : Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 97 : Eastern Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 98 : Eastern Europe Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 99 : Eastern Europe Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 100 : Czech Republic Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 101 : Czech Republic Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 102 : Poland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 103 : Poland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 104 : Romania Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 105 : Romania Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 106 : Russia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 107 : Russia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 108 : Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 109 : North America Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 110 : North America Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 111 : North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 112 : North America Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 113 : North America Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 114 : North America Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 115 : Canada Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 116 : Canada Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 117 : Mexico Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 118 : Mexico Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 119 : USA Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 120 : USA Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 121 : USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 122 : South America Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 123 : South America Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 124 : South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 125 : South America Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 126 : South America Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 127 : South America Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 128 : Argentina Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 129 : Argentina Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 130 : Brazil Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 131 : Brazil Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 132 : Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 133 : Chile Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 134 : Chile Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 135 : Colombia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 136 : Colombia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 137 : Peru Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 138 : Peru Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 139 : Venezuela Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 140 : Venezuela Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 141 : Middle East Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 142 : Middle East Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 143 : Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 144 : Middle East Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 145 : Middle East Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 146 : Middle East Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 147 : Saudi Arabia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 148 : Saudi Arabia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 149 : Israel Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 150 : Israel Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 151 : Turkey Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 152 : Turkey Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 153 : UAE Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 154 : UAE Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 155 : Africa Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 156 : Africa Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 157 : Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 158 : Africa Oncology Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 159 : Africa Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 160 : Africa Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 161 : Egypt Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 162 : Egypt Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 163 : Nigeria Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 164 : Nigeria Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 165 : South Africa Oncology Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 166 : South Africa Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 167 : Global Oncology Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 168 : Bristol-Myers Squibb Company – Financial Performance, 2016 – 2020, $ Billion
  • Figure 169 : F. Hoffmann-La Roche AG – Financial Performance, 2016 – 2020, $ Billion
  • Figure 170 : Merck & Co., Inc. – Financial Performance, 2016-2020, $ Billion
  • Figure 171 : Novartis AG – Financial Performance, 2016 – 2020, $ Billion
  • Figure 172 : Johnson & Johnson (J&J) – Financial Performance, 2016 – 2020, $ Billion
  • Figure 173 : Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
  • Figure 174 : Global Pharmaceutical Drugs Market, 2020, Split By Region
  • Figure 175 : Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report